The results showed that, compared with matched adjacent non-tumor liver tissues (ANLTs), the expression level of JARID2 in HCC tissues (T) was significantly up-regulated (fold change (T/ANLT) > 2) in 73.3% cases (22/30) (Figure 1A). This evidence concerns the gene JARID2 and hepatocellular carcinoma.